Precigen Inc (NASDAQ:PGEN)
| 1.43 Delayed Data As of Sep 29 |  +0.01 / +0.70%Today’s Change | 0.81 Today|||52-Week Range 2.29 | -5.92% Year-to-Date |
Latest PGEN News | Press Releases
No recent news for Precigen Inc.
Today’s Trading
| Previous close | 1.42 |
| Today’s open | 1.43 |
| Day’s range | 1.39 - 1.46 |
| Volume | 46,630 |
| Average volume (3 months) | 1,542,359 |
| Market cap | $357.7M |
Data as of 3:59pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +28.91% |
| Earnings growth (this year) | -6.04% |
| Earnings growth (next 5 years) | -78.25% |
| Revenue growth (last year) | -74.09% |
| P/E ratio | NM |
| Price/Sales | 11.32 |
| Price/Book | 2.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RCELAVITA Medical Inc | +0.01 | +0.07% |
| SIGASIGA Technologies In... | +0.01 | +0.29% |
| ---- | ||
| ALDXAldeyra Therapeutics... | +0.42 | +6.79% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $26.9M |
| Annual profit (last year) | -$66.4M |
| Net profit margin | -296.47% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Germantown, Maryland |
Forecasts
